- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-01-0034308

About Avantika Medex Private Limited
Data last updated:
Avantika Medex Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Avl Life Science Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51397GJ2007PTC082606. Its GSTIN is 24AAGCA5648H1ZO (Gujarat).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.03 Cr. It is led by directors Vibha Rani Singh and Lal Babu Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1308 Shapath – V Near Prahalad Nagar Junction S.G.Road Vejalpur, Ahmedabad, Gujarat, India – 380051.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.37 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.75 Cr (net margin 3.9%) and EBITDA of ₹4.54 Cr (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 18% over five years.
The company has about 138 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.13 Cr and satisfied charges of ₹20.97 Cr on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it. The company has 1 deal on record (1 rights issue); the latest was in April 2019. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Admed Pharma Private Limited with revenue of ₹44.5 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers.
Avantika Medex Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0034308). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avantikamedexpl.com.
Company details
CIN history
Avantika Medex has one previous CIN (Corporate Identification Number): U51397DL2007PTC168345. The current CIN is U51397GJ2007PTC082606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397GJ2007PTC082606 | Current |
| U51397DL2007PTC168345 | Previous |
Recognitions & Rankings of Avantika Medex
Contact details
Avantika Medex Private Limited's registered office is in Ahmedabad, Gujarat. Its website is avantikamedexpl.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1308 Shapath – V Near Prahalad Nagar Junction S.G.Road Vejalpur, Ahmedabad, Gujarat, India – 380051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avantika Medex Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avantika Medex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avantika Medex Private Limited, buy the company report.
Financials of Avantika Medex Private Limited
FY 2024 filings availableAvantika Medex Private Limited reported revenue of ₹44.37 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.75 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avantika Medex Private Limited, buy the company report.
Board of directors of Avantika Medex Private Limited
Avantika Medex has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vibha Rani Singh Also directs: Avl Life Science Private Limited | Director | 18 Sep 2007 | 19 Years 1 Months | Current |
| Lal Babu Singh Also directs: Avl Life Science Private Limited | Director | 18 Sep 2007 | 19 Years 1 Months | Current |
Peer comparison
Avantika Medex Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Admed Pharma Private Limited | ₹44.5 Cr (FY 2025) | 17.0% | Delhi, India | |||
| Lincoln Parenteral Limited | ₹44.48 Cr (FY 2020) | -13.0% | Ahmedabad, Gujarat, India | |||
| Avantika Medex Private Limitedthis company | ₹44.37 Cr (FY 2025) | ₹1.75 Cr | 3.9% | -14.0% | 138 | Ahmedabad, Gujarat, India |
| Lexicon Worldwide Limited | ₹44.19 Cr (FY 2024) | 37.0% | Solan Hp, Himachal Pradesh, India | |||
| Affine Formulations Limited | ₹44.05 Cr (FY 2022) | 4.0% | Indore, Madhya Pradesh, India | |||
| Quality Pharma Products Private Limited | ₹43.95 Cr (FY 2025) | 22.0% | Assam, India |
To see the full peer comparison of Avantika Medex Private Limited, buy the company report.
Auditor
Avantika Medex Private Limited is audited by LAKHANI ISMAILI TUNDIYA & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| LAKHANI ISMAILI TUNDIYA & CO | FY 2024 | 119573W |
Shareholding
The shareholding of Avantika Medex Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avantika Medex Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2022 | 100654925 | Axis Bank Limited | ₹93.07 Lakh | Open | |
| 05 Feb 2014 | 10476307 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 29 Dec 2023 | 100862070 | Others | ₹9.9 Cr | Satisfied | |
| 04 Oct 2019 | 100303673 | The South Indian Bank Limited | ₹9.62 Cr | Satisfied | |
| 05 May 2015 | 10581573 | Hdfc Bank Limited | ₹1.46 Cr | Satisfied |
To see the full charge records of Avantika Medex Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Avantika Medex Private Limited has 1 deal on record (1 rights issue); the latest was in April 2019.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2019 | Rights issue | ₹2.37 Cr | Investors: Avl Life Science Private Limited , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Avantika Medex Private Limited has 4 court cases on record: 1 filed by Avantika Medex, 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Marion Biotech Pvt Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Court case (AGRMNT LC) | Filed against the company by an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (PWAPP LC) | Filed against the company by an individual | Disposed |
| High Court, GUJARAT | Court case (SCR.A) | Filed by the company against State of Gujarat and 1 other | Disposed |
To see the full case history of Avantika Medex Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Avantika Medex Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Nexus Infratech Private Limited |
To see the full MSME payment records of Avantika Medex Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Avantika Medex Private Limited has a workforce of 138 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 138 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Avantika Medex Private Limited, buy the company report.
GST
Avantika Medex has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCA5648H1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avantika Medex Private Limited, buy the company report.
Recent activity
Avantika Medex Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Lal Babu Singh was appointed as Director on 18 Sep 2007.
4 earlier events are in the company report.
Frequently asked questions
Avantika Medex is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 2007 (19+ years old) and is registered under CIN U51397GJ2007PTC082606.
Avantika Medex has 2 current directors:
- Vibha Rani Singh - Director
- Lal Babu Singh - Director
The latest financial statements of Avantika Medex on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Avantika Medex is 24AAGCA5648H1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Avantika Medex is U51397GJ2007PTC082606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avantika Medex has 4 court cases on record: 1 filed by the company and 3 filed against it. Most are in the district courts.
Avantika Medex was incorporated on 18 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Avantika Medex has 1 deal on record (1 rights issue); the latest was in April 2019.
The peers of Avantika Medex by revenue are Admed Pharma Private Limited, Lincoln Parenteral Limited, Lexicon Worldwide Limited, Affine Formulations Limited, Quality Pharma Products Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lal Babu Singh was appointed as Director on 18 Sep 2007. Vibha Rani Singh was appointed as Director on 18 Sep 2007.
Yes, Avantika Medex is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-01-0034308).
Avantika Medex has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. The latest return was filed on 08 Jun 2019.

